Your session is about to expire
← Back to Search
NeuroCognitive Communicator for Motor Impairments (NCC-1701 Trial)
NCC-1701 Trial Summary
This trial will test whether two sensors, each a microelectrode array, implanted into both the motor and cognitive regions of the brain can help people with motor impairments.
NCC-1701 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNCC-1701 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NCC-1701 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: NeuroCognitive Communicator
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
Is participation in this research endeavor open to individuals?
"This clinical trial is attempting to recruit two individuals with quadriplegia between the legal age of majority and 70 years old. The must-have criteria for applicants are: local residence within one hour travel from the site, as well as psychological and social stability."
How many participants are being sought for this clinical trial?
"Affirmative. According to clinicaltrials.gov, the trial is still ongoing and has been open since 13 May 2019 with its most recent update on 28 July 2022. At present, only two patients are being recruited from a single medical facility."
Is eligibility for this research study limited to individuals under 30 years old?
"This study is open to any individual aged 18-70. For those younger than 18 or above 65, there are 5 and 161 studies respectively that may better suit their criteria."
Is this exploration presently recruiting participants?
"Affirmative, the evidence on clinicaltrials.gov indicates that this research project is actively recruiting participants. It was first made available to the public on May 13th 2019 and has had a recent update July 28th 2022; 2 individuals are being sought from one site for enrollment."
Share this study with friends
Copy Link
Messenger